These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27006301)

  • 1. Activating BRAF Mutations Detected in Mixed Hürthle Cell Carcinoma and Multifocal Papillary Carcinoma of the Thyroid Gland: Report of an Unusual Case and Review of the Literature.
    Sinno S; Choucair M; Nasrallah M; Wadi L; Jabbour MN; Nassif S
    Int J Surg Pathol; 2016 Sep; 24(6):519-24. PubMed ID: 27006301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicular histotypes of oncocytic thyroid carcinomas do not carry mutations of the BRAF hot-spot.
    Musholt PB; Musholt TJ; Morgenstern SC; Worm K; Sheu SY; Schmid KW
    World J Surg; 2008 May; 32(5):722-8. PubMed ID: 18235983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of EZH1 mutations in the diagnosis of follicular-patterned thyroid tumors.
    Jung CK; Kim Y; Jeon S; Jo K; Lee S; Bae JS
    Hum Pathol; 2018 Nov; 81():9-17. PubMed ID: 29723601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occult oncocytic papillary thyroid carcinoma with lymphoid stroma (Warthin-like tumor): report of a case with concomitant mutations of BRAF V600E and V600K.
    Han F; Zhang L; Zhang S; Zhou H; Yi X
    Int J Clin Exp Pathol; 2015; 8(5):5896-901. PubMed ID: 26191315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
    Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
    Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of differential BRAF(V600E) mutational status in multifocal papillary thyroid carcinoma: evidence of independent clonal origin in distinct tumor foci.
    Park SY; Park YJ; Lee YJ; Lee HS; Choi SH; Choe G; Jang HC; Park SH; Park DJ; Cho BY
    Cancer; 2006 Oct; 107(8):1831-8. PubMed ID: 16983703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EIF1AX Mutation in a Patient with Hürthle Cell Carcinoma.
    Topf MC; Wang ZX; Furlong K; Miller JL; Tuluc M; Pribitkin EA
    Endocr Pathol; 2018 Mar; 29(1):27-29. PubMed ID: 28965201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathology of well-differentiated thyroid carcinomas.
    Sobrinho-Simões M; Preto A; Rocha AS; Castro P; Máximo V; Fonseca E; Soares P
    Virchows Arch; 2005 Nov; 447(5):787-93. PubMed ID: 16189702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant.
    Smith RA; Salajegheh A; Weinstein S; Nassiri M; Lam AK
    Hum Pathol; 2011 Apr; 42(4):500-6. PubMed ID: 21167555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encapsulated papillary oncocytic neoplasms of the thyroid: morphologic, immunohistochemical, and molecular analysis of 18 cases.
    Woodford RL; Nikiforov YE; Hunt JL; Bellizzi AM; Zhang X; Mills SE; Stelow EB
    Am J Surg Pathol; 2010 Nov; 34(11):1582-90. PubMed ID: 20924280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicentric occurrence of multiple papillary thyroid carcinomas--HUMARA and BRAF mutation analysis.
    Nakazawa T; Kondo T; Tahara I; Kasai K; Inoue T; Oishi N; Mochizuki K; Kubota T; Katoh R
    Cancer Med; 2015 Aug; 4(8):1272-80. PubMed ID: 25882744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicular variant of papillary thyroid carcinoma with B-type Raf(V600E) showing higher frequency of suspicious sonographic features and multifocality.
    Shin DY; Kim KJ; Chang S; Kim H; Hwang S; Kim W; Bae J; Park S; Kang SW; Chung WY; Lee EJ
    Head Neck; 2015 Nov; 37(11):1590-5. PubMed ID: 24909403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRAF(K601E) mutation in a patient with a follicular thyroid carcinoma.
    Pennelli G; Vianello F; Barollo S; Pezzani R; Merante Boschin I; Pelizzo MR; Mantero F; Rugge M; Mian C
    Thyroid; 2011 Dec; 21(12):1393-6. PubMed ID: 22136270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synchronous and Metastatic Papillary and Follicular Thyroid Carcinomas with Unique Molecular Signatures.
    Cracolici V; Mujacic I; Kadri S; Alikhan M; Niu N; Segal JP; Rosen LE; Sarne DH; Morgan A; Desouky S; Cipriani NA
    Endocr Pathol; 2018 Mar; 29(1):9-14. PubMed ID: 28710706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma.
    Kim TY; Kim WB; Song JY; Rhee YS; Gong G; Cho YM; Kim SY; Kim SC; Hong SJ; Shong YK
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):588-93. PubMed ID: 16268813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRAF V600E mutation in anaplastic thyroid carcinomas and their accompanying differentiated carcinomas.
    Takano T; Ito Y; Hirokawa M; Yoshida H; Miyauchi A
    Br J Cancer; 2007 May; 96(10):1549-53. PubMed ID: 17453004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple Mutations Detected Preoperatively May Predict Aggressive Behavior of Papillary Thyroid Cancer and Guide Management--A Case Report.
    Shrestha RT; Karunamurthy A; Amin K; Nikiforov YE; Caramori ML
    Thyroid; 2015 Dec; 25(12):1375-8. PubMed ID: 26355276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TERT promoter mutations in thyroid cancer: a report from a Middle Eastern population.
    Qasem E; Murugan AK; Al-Hindi H; Xing M; Almohanna M; Alswailem M; Alzahrani AS
    Endocr Relat Cancer; 2015 Dec; 22(6):901-8. PubMed ID: 26354077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, tumorigenic role, and biochemical implications of rare BRAF alterations.
    Barollo S; Pezzani R; Cristiani A; Redaelli M; Zambonin L; Rubin B; Bertazza L; Zane M; Mucignat-Caretta C; Bulfone A; Pennelli G; Casal Ide E; Pelizzo MR; Mantero F; Moro S; Mian C
    Thyroid; 2014 May; 24(5):809-19. PubMed ID: 24295088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment.
    Begum S; Rosenbaum E; Henrique R; Cohen Y; Sidransky D; Westra WH
    Mod Pathol; 2004 Nov; 17(11):1359-63. PubMed ID: 15195111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.